Biography

Prof. Mirza R. Baig is the Associate Dean of Clinical Affairs at DPCG. He has an extensive background in clinical pharmacy, with a PhD from Universiti Sains Malaysia (USM) and several years of experience in research and academia. His research work primarily focuses on pharmacoepidemiology, public health, pharmacoeconomics, and drug-related problems. Prof. Baig is widely published in his field, and his contributions span across various topics, including drug utilization studies and systematic reviews.

Education

• PhD in Clinical Pharmacy from Universiti Sains Malaysia (USM), 2011.
• M.Pharm from RGUHS, India, 2003.
• B.Pharm from Gulbarga University, India, 2000.

Research Interests

• Pharmacoepidemiology, Public Health
• Pharmacoeconomics, Drug Utilization Studies
• Pharmaceutical Care, Drug-Related Problems
• Systematic Reviews & Meta-Analysis

Research Publications

• Soufi Amlashi, N., Mahmood, F. R., Baig, M. R., Kadhem, M., & Ebrahimi, A. (2026). Spirulina supplementation and human health: An umbrella review of meta-analysis on randomized controlled trials. Algal Research, 95, 104571.
• Hsu, C. Y., Baig, M. R., Patel, P. N., Priyadarshini Nayak, P. P., & Iqbal, M. S. (2026). Innovative approaches to irinotecan-based therapies for glioblastoma: Advancements in drug delivery and combination strategies. Critical Reviews in Oncology/Hematology, 219, 105144.
• Mehanna, M. G., Asar, T. O., Mudasir, H. C., Kumar, V., & Anwar, F. (2025). Biochemical insight into gut microbial imbalance in Covid-19 and post vaccination heart attacks. World Journal of Microbiology and Biotechnology, 41(7), 206.
• Sheikh, R. A., Naqvi, S., Al-Sulami, A. M., Asar, T. O., & Anwar, F. (2025). Synchronized glioma insights: Trends, blood group correlations, staging dynamics, and the vanguard of liquid biopsy advancements. CNS and Neurological Disorders – Drug Targets, 24(1), 74–82.
• Selim, F., Baig, M. R., Magoury, M., Ahmed, W., & Mahmoud, M. A. (2025). Drug therapy-related problems detected by clinical pharmacists in a closed loop medication management: A cross-sectional study in UAE. Archives of Academic Emergency Medicine, 13(1), e16.
• Alharbi, M. O., Eid, T. M., Baig, M. R., Kumar, V., & Anwar, F. (2025). Prospective clinical and biochemical evaluation of breast cancer in patient cohorts. Current Cancer Drug Targets (Article in press).
• Almalki, N. A. R., Alharbi, M. O., Baig, M. R., Usaid, M., & Anwar, F. (2025). Biochemical landscape of breast cancer: Integrating serum markers with clinical prognosis and staging. Clinical and Translational Oncology (Article in press).
• Almukhattin, M. S. H., Abdulsalim, S., Alawadhi, S. M. S., Miraj, S. S., & Abdulkader, N. (2025). Prevalence and predictors of albuminuria in type 2 diabetes mellitus patients: A cross-sectional study from the United Arab Emirates. Current Diabetes Reviews, 21(10), E141022209956.
• Alkireidmi, M. A., Mehanna, M. G., Baig, M. R., Kumar, V., & Anwar, F. (2025). Clinicopathological and in silico insights into male infertility: Age-related trends and anti-sperm antibodies post COVID-19 vaccination. Current Medicinal Chemistry, 32(25), 5350–5365.
• El-Sehrawy, A. A. M. A., Aljumaili, O. I., Baig, M. R., Smerat, A., & Basunduwah, T. S. (2027). Diagnostic and prognostic biomarkers in PCOS: Navigating insulin resistance, systemic inflammation, and endometrial receptivity. Clinica Chimica Acta, 592, 121197.
• Abdelgawwad El-Sehrawy, A. A. M., Radhie, S. H., Baig, M. R., Smerat, A., & Alnajar, M. J. (2026). MicroRNA–SIRT1 crosstalk in liver diseases: Molecular regulation of metabolism, inflammation, and cell survival. Molecular Biology Reports, 53(1), 899.
• Chama, Z., Yousif, A. Y., Patel, P. N., Iqbal, M. S., & Basunduwah, T. S. (2026). Nanomedicine strategies targeting STAT3 in cancer: From tumor suppression to microenvironment modulation. Journal of Pharmacology and Experimental Therapeutics, 393(7), 104954.
• El-Sehrawy, A. A. M. A., Saleh, N. M., Nematov, O. N., Basunduwah, T. S., & Badr, I. H. (2026). Engineering microspheres for breast cancer: Integrating tumor modeling, diagnostics, and targeted treatment. DARU, Journal of Pharmaceutical Sciences, 34(1), 26.
• Hsu, C. Y., Abdelrahim, I. M., Hjazi, A. M., Samantsinghar, P., & Singh, G. (2026). Self-assembled nanovaccines: A promising strategy for overcoming influenza variability and advancing universal vaccine development. IUBMB Life, 78(4), e70097.
• Hsu, C. Y., El-Sehrawy, A. A. M. A., Baig, M. R., Shukla, S. K., & Priyadarshini Nayak, P. P. (2026). Metabolic adaptation in colorectal cancer microenvironment: Focus on cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs). Experimental Cell Research, 455(1), 114867.
• Hsu, C. Y., Raval, A. D., Bainsal, N., Alghazali, T. A. H., & Smerat, A. (2026). Molecular regulation of pyroptosis in Alzheimer’s disease: Linking neuroinflammation, cell death, and therapeutic targeting. Molecular Neurobiology, 63(1), 760.
• El-Sehrawy, A. A. M. A., Alkhayyat, S., Baig, M. R., Smerat, A., & Fereydouni, N. (2026). Injectable bioactive hydrogels as pharmacological drug delivery platforms for post-myocardial infarction cardiac repair: Therapeutic cargo engineering, stimuli-responsive release mechanisms, and translational perspectives. Naunyn-Schmiedeberg’s Archives of Pharmacology (Article in press).
• Assadi, R. A., Beshir, S. A., Shahiwala, A. F., & Baig, M. R. (2025). A narrative review of preceptor roles and models of precepting in pharmacy practice experiential learning: A UAE perspective. International Journal of Pharmacy Practice, 33(6), 545–554.
• Bose, S., Banerjee, S., Chatterjee, S., Baig, M. R., & Singh, N. (2025). Oats and wheat bran as functional food and nutraceuticals. In Dietary Supplements and Nutraceuticals (pp. 281–297).
• Mehanna, M. G., Asar, T. O., Mudasir, H. C., Kumar, V., & Anwar, F. (2025). Correction: Biochemical insight into gut microbial imbalance in Covid-19 and post vaccination heart attacks. World Journal of Microbiology and Biotechnology, 41(10), 357.